Search details
1.
An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma.
CA Cancer J Clin
; 72(5): 454-489, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35708940
2.
Genomic ancestry in kidney cancer: Correlations with clinical and molecular features.
Cancer
; 130(5): 692-701, 2024 03 01.
Article
in English
| MEDLINE | ID: mdl-37864521
3.
NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024.
J Natl Compr Canc Netw
; 22(1): 4-16, 2024 02.
Article
in English
| MEDLINE | ID: mdl-38394781
4.
Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer Patients.
J Urol
; 209(5): 918-927, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36974724
5.
Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variants.
Cancer
; 128(21): 3870-3879, 2022 11 01.
Article
in English
| MEDLINE | ID: mdl-36041233
6.
Early age of onset and broad cancer spectrum persist in MSH6- and PMS2-associated Lynch syndrome.
Genet Med
; 24(6): 1187-1195, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35346574
7.
Association of Family History of Cancer with Clinical and Pathological Outcomes for Prostate Cancer Patients on Active Surveillance.
J Urol
; 208(2): 325-332, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35377777
8.
Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(1): 71-90, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34991070
9.
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement.
Cancer
; 127(21): 3957-3966, 2021 Nov 01.
Article
in English
| MEDLINE | ID: mdl-34343338
10.
Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer.
Genet Med
; 23(11): 2105-2113, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34257420
11.
Fumarate hydratase FH c.1431_1433dupAAA (p.Lys477dup) variant is not associated with cancer including renal cell carcinoma.
Hum Mutat
; 41(1): 103-109, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31444830
12.
Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial.
Cancer
; 126(24): 5247-5255, 2020 12 15.
Article
in English
| MEDLINE | ID: mdl-32975815
13.
11p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood.
Cancer
; 126(13): 3114-3121, 2020 07 01.
Article
in English
| MEDLINE | ID: mdl-32320050
14.
NCCN Guidelines Insights: Kidney Cancer, Version 1.2021.
J Natl Compr Canc Netw
; 18(9): 1160-1170, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32886895
15.
Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: A braided cancer river model of kidney cancer.
Semin Cell Dev Biol
; 64: 98-106, 2017 04.
Article
in English
| MEDLINE | ID: mdl-27615548
16.
Tumor cell heterogeneity and resistance; report from the 2018 Coffey-Holden Prostate Cancer Academy Meeting.
Prostate
; 79(3): 244-258, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30381857
17.
Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases.
Mod Pathol
; 32(9): 1329-1343, 2019 09.
Article
in English
| MEDLINE | ID: mdl-30980040
18.
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
JAMA
; 318(9): 825-835, 2017 09 05.
Article
in English
| MEDLINE | ID: mdl-28873162
19.
A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma.
Oncologist
; 21(7): 787-8, 2016 07.
Article
in English
| MEDLINE | ID: mdl-27286790
20.
The Prevalence and Radiologic Features of Renal Cancers Associated with FLCN, BAP1, SDH, and MET Germline Mutations.
Radiol Imaging Cancer
; 6(2): e230063, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38456787